Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by University of Vermont
Michael J. Fox Foundation for Parkinson's Research
Parkinson Study Group (PSG)
International Parkinson Fonds (IPF)
German Parkinson Study Group (GPS)
German Parkinson Society (DPG)
Philipps-University Marburg, Germany
Information provided by (Responsible Party):
James BOYD MD, University of Vermont
ClinicalTrials.gov Identifier:
First received: March 9, 2012
Last updated: November 13, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)